IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

IMCAS Americas 2017
Program

FOCUS ON SESSION 035

Injectables for different ages and morphotypes

Room: Room 1
Date: Saturday 25 March 2017 at 16:00 to 17:00
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chairs

Dr Pierre NICOLAU

Plastic Surgeon

Spain

Dr Frank ROSENGAUS

Facial Plastic Surgeon

Mexico

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
16:00	Dr Angel Camilo PENARANDA URBINA	“Full face” botulinum toxin for Latam morphotypes		37780
16:10	Dr Sergio Omar ESCOBAR	Difficult areas to treat in different ages and morphotypes	View	32964
16:20	Dr Alessandra HADDAD	Ethnic considerations in facial rejuvenation	View	46618
16:30	Prof Gary D MONHEIT	New and established uses of botulinum toxin for USA vs Latam morphotypes	View	47588
16:40	Prof Maria Jose PELLI	The state of the art in aesthetics in Latin America	View	48000
16:50		Questions & answers		53107

Go to previous session

Go to next session

Recommended sessions

Ethnic morphologies

Botulinum toxins

Fillers: HA (hyaluronic acid)

Beauty norms

Dr Angel Camilo PENARANDA URBINA

Dermatologist

Colombia

Other author(s) :

“Full face” botulinum toxin for Latam morphotypes

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Sergio Omar ESCOBAR

Dermatologist

Argentina

Other author(s) :

Difficult areas to treat in different ages and morphotypes

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Alessandra HADDAD

Plastic Surgeon

Brazil

Other author(s) :

Ethnic considerations in facial rejuvenation

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Gary D MONHEIT

Dermatologist

United States

Other author(s) :

New and established uses of botulinum toxin for USA vs Latam morphotypes

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): 1.Allergan Corporation •Consultant and Clinical Investigator 2. Revance •Consultant and Clinical Investigator 3.Galderma •Consultant and Clinical Investigator 4.Merz • Consultant and Clinical Investigator 5. Suneva • Consultant and Clinical Investigator 6.Teoxane Clinical Investigator 7.Alphaeon •Clinical Investigator 8.CROMA •Clinical Investigator 9.Evolus •Clinical Investigator

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): 1. Allergan Corporation •Consultant and Clinical Investigator 2. Revance •Consultant and Clinical Investigator 3. Galderma •Consultant and Clinical Investigator 4. Merz •Consultant and Clinical Investigator 5.Suneva •Consultant and Clinical Investigator 6.Teoxane •Clinical Investigator 7.Alphaeon •Clinical Investigator 8.CROMA •Clinical Investigator 9.Evolus • Clinical Investigator

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Maria Jose PELLI

Dermatologist

Argentina

Other author(s) :

The state of the art in aesthetics in Latin America

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Questions & answers

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Americas 2017 Program

FOCUS ON SESSION 035

Injectables for different ages and morphotypes

Chairs

Lectures of the session

Recommended sessions

IMCAS Americas 2017
Program